Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Everolimus monotherapy or combined therapy in liver transplantation: indications and results.

Alegre C, Jiménez C, Manrique A, Abradelo M, Calvo J, Loinaz C, García-Sesma A, Cambra F, Alvaro E, García M, Sanabria R, Justo I, Caso O, Moreno E.

Transplant Proc. 2013 Jun;45(5):1971-4. doi: 10.1016/j.transproceed.2013.01.075.

PMID:
23769086
2.

Indications and management of everolimus after liver transplantation.

Bilbao I, Sapisochin G, Dopazo C, Lazaro JL, Pou L, Castells L, Caralt M, Blanco L, Gantxegi A, Margarit C, Charco R.

Transplant Proc. 2009 Jul-Aug;41(6):2172-6. doi: 10.1016/j.transproceed.2009.06.087.

PMID:
19715864
3.

Improvement of renal function after the switch from a calcineurin inhibitor to everolimus in liver transplant recipients with chronic renal dysfunction.

Castroagudín JF, Molina E, Romero R, Otero E, Tomé S, Varo E.

Liver Transpl. 2009 Dec;15(12):1792-7. doi: 10.1002/lt.21920.

4.

Everolimus in clinical practice in long-term liver transplantation: an observational study.

Casanovas T, Argudo A, Peña-Cala MC.

Transplant Proc. 2011 Jul-Aug;43(6):2216-9. doi: 10.1016/j.transproceed.2011.06.015.

PMID:
21839237
5.

Everolimus with reduced calcineurin inhibitor in thoracic transplant recipients with renal dysfunction: a multicenter, randomized trial.

Gullestad L, Iversen M, Mortensen SA, Eiskjaer H, Riise GC, Mared L, Bjørtuft O, Ekmehag B, Jansson K, Simonsen S, Gude E, Rundqvist B, Fagertun HE, Solbu D, Bergh CH.

Transplantation. 2010 Apr 15;89(7):864-72. doi: 10.1097/TP.0b013e3181cbac2d.

PMID:
20061999
6.

Renal function improves in liver transplant recipients when switched from a calcineurin inhibitor to sirolimus.

Fairbanks KD, Eustace JA, Fine D, Thuluvath PJ.

Liver Transpl. 2003 Oct;9(10):1079-85.

7.

Conversion to everolimus in kidney transplant recipients: to believe or not believe?

Cotovio P, Neves M, Santos L, Macário F, Alves R, Mota A.

Transplant Proc. 2012 Dec;44(10):2966-70. doi: 10.1016/j.transproceed.2012.06.072.

PMID:
23195007
8.

Sirolimus in liver transplant recipients: a large single-center experience.

Vivarelli M, Dazzi A, Cucchetti A, Gasbarrini A, Zanello M, Di Gioia P, Bianchi G, Tamè MR, Gaudio MD, Ravaioli M, Cescon M, Grazi GL, Pinna AD.

Transplant Proc. 2010 Sep;42(7):2579-84. doi: 10.1016/j.transproceed.2010.04.045.

PMID:
20832548
9.

Conversion to everolimus in liver transplant patients with renal dysfunction.

Pérez T, Segovia R, Castro L, Roblero JP, Estela R.

Transplant Proc. 2011 Jul-Aug;43(6):2307-10. doi: 10.1016/j.transproceed.2011.06.009.

PMID:
21839260
10.

Experience of using everolimus in the early stage of living donor liver transplantation.

Jeng LB, Thorat A, Hsieh YW, Yang HR, Yeh CC, Chen TH, Hsu SC, Hsu CH.

Transplant Proc. 2014 Apr;46(3):744-8. doi: 10.1016/j.transproceed.2013.11.068.

PMID:
24767339
11.

Use of everolimus as a rescue immunosuppressive therapy in liver transplant patients with neoplasms.

Gomez-Camarero J, Salcedo M, Rincon D, Lo Iacono O, Ripoll C, Hernando A, Sanz C, Clemente G, Bañares R.

Transplantation. 2007 Sep 27;84(6):786-91.

PMID:
17893613
12.

Adverse events affect sorafenib efficacy in patients with recurrent hepatocellular carcinoma after liver transplantation: experience at a single center and review of the literature.

Zavaglia C, Airoldi A, Mancuso A, Vangeli M, Viganò R, Cordone G, Gentiluomo M, Belli LS.

Eur J Gastroenterol Hepatol. 2013 Feb;25(2):180-6. doi: 10.1097/MEG.0b013e328359e550. Review.

PMID:
23044808
13.

The impact of everolimus on renal function in maintenance liver transplantation.

De Simone P, Precisi A, Petruccelli S, Balzano E, Carrai P, Catalano G, Campani D, Filipponi F.

Transplant Proc. 2009 May;41(4):1300-2. doi: 10.1016/j.transproceed.2009.03.051.

PMID:
19460545
14.

Renal function improvement in liver transplant recipients after early everolimus conversion: A clinical practice cohort study in Spain.

Bilbao I, Salcedo M, Gómez MA, Jimenez C, Castroagudín J, Fabregat J, Almohalla C, Herrero I, Cuervas-Mons V, Otero A, Rubín A, Miras M, Rodrigo J, Serrano T, Crespo G, De la Mata M, Bustamante J, Gonzalez-Dieguez ML, Moreno A, Narvaez I, Guilera M; EVEROLIVER study group..

Liver Transpl. 2015 Aug;21(8):1056-65. doi: 10.1002/lt.24172.

15.

Conversion to everolimus in maintenance liver transplant patients: a multicenter, retrospective analysis.

Saliba F, Dharancy S, Lorho R, Conti F, Radenne S, Neau-Cransac M, Hurtova M, Hardwigsen J, Calmus Y, Dumortier J.

Liver Transpl. 2011 Aug;17(8):905-13. doi: 10.1002/lt.22292.

16.

Impact of the conversion of the immunosuppressive regimen from prograf to advagraf or to sirolimus in long-term stable liver transplant recipients: indications, safety, and outcome.

Perrakis A, Schwarz K, Yedibela S, Croner RS, Hohenberger W, Müller V.

Transplant Proc. 2011 Dec;43(10):3702-7. doi: 10.1016/j.transproceed.2011.09.015.

PMID:
22172830
17.

Everolimus with reduced-dose cyclosporine versus full-dose cyclosporine and mycophenolate in de novo renal transplant patients: a 2-year single-center experience.

Santos SM, Carlos CM, Cabanayan-Casasola CB, Danguilan RA.

Transplant Proc. 2012 Jan;44(1):154-60. doi: 10.1016/j.transproceed.2011.11.055.

PMID:
22310603
18.

Calcineurin inhibitor-free immunosuppression using everolimus (Certican) after heart transplantation: 2 years' follow-up from the University Hospital Münster.

Stypmann J, Engelen MA, Eckernkemper S, Amler S, Gunia S, Sindermann JR, Rothenburger M, Rukosujew A, Drees G, Welp HA.

Transplant Proc. 2011 Jun;43(5):1847-52. doi: 10.1016/j.transproceed.2010.12.062.

PMID:
21693288
19.

A retrospective 12-month study of conversion to everolimus in lung transplant recipients.

Roman A, Ussetti P, Zurbano F, Borro JM, Solé A, Carreño MC, Santos F.

Transplant Proc. 2011 Sep;43(7):2693-8. doi: 10.1016/j.transproceed.2011.06.028.

PMID:
21911148
20.

Conversion from a calcineurin inhibitor to everolimus therapy in maintenance liver transplant recipients: a prospective, randomized, multicenter trial.

De Simone P, Metselaar HJ, Fischer L, Dumortier J, Boudjema K, Hardwigsen J, Rostaing L, De Carlis L, Saliba F, Nevens F.

Liver Transpl. 2009 Oct;15(10):1262-9. doi: 10.1002/lt.21827.

Items per page

Supplemental Content

Support Center